Bluewillow Biologics Inc
Div Na
CAGE Code: 3HT71
NCAGE Code: 3HT71
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 177653487
Summary
Bluewillow Biologics Inc, Div Na is an Active Commercial Supplier with the Cage Code 3HT71 and is tracked by Dun & Bradstreet under DUNS Number 177653487..
Address
2311 Green Rd
Ste A
Ann Arbor MI 48105-2965
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Micrometrical Development Corp Jiffy Tool Supply Co Inc Languages Of The Americas Analytic Solutions Trans Continental Airlines University Of Michigan Michigan Sea Medical Imaging Resources, Inc. Emag Technologies Inc. Aviat Inc Baladyne Corporation Analytical Luminescence Fall Arrest Systems Inc P O Box 271 Aaa Micro Cleaning Ex-Tac Inc Atwell-Hicks Michigan, Llc Culturewell, Co. Stratosware Corp Ck Systems, Inc. Mindsemerge Inc. Program Planning Professionals, Inc
Frequently Asked Questions (FAQ) for CAGE 3HT71
- What is CAGE Code 3HT71?
- 3HT71 is the unique identifier used by NATO Organizations to reference the physical entity known as Bluewillow Biologics Inc Div Na located at 2311 Green Rd, Ste A, Ann Arbor MI 48105-2965, United States.
- Who is CAGE Code 3HT71?
- 3HT71 refers to Bluewillow Biologics Inc Div Na located at 2311 Green Rd, Ste A, Ann Arbor MI 48105-2965, United States.
- Where is CAGE Code 3HT71 Located?
- CAGE Code 3HT71 is located in Ann Arbor, MI, USA.
Contracting History for CAGE 3HT71 Most Recent 25 Records
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy.
- 23 Aug 2019
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 28 Aug 2020
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Eo14042 - Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 12 Oct 2021
- Eo14042 - Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 3 Sep 2020
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 2 Jun 2023
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 26 Aug 2022
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 30 Jan 2023
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 20 Jun 2023
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,295,688.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 5 Apr 2021
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 2 Jul 2021
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- 26 Aug 2022
- Development Of Nanovax Tm (Oil In Water Nanoemulsion Adjuvant) Formulated Allergens As Intranasal Immunotherapeutic Vaccines For Peanut Allergy. Phase Ii.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00035
- Revised Statement Of Work.
- 27 Sep 2019
- Revised Statement Of Work.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,216,388.00
- Department Of Health And Human Services (Hhs)